Joan Carles

Home Tag

Joan Carles- web

ASCO 2023: novel treatment combination shows promise as first-line treatment in patients with metastatic castration-resistant prostate cancer

New additional data from the phase 3 TALAPRO-2 study, presented today at the 2023 Annual Meeting of the American Society…

Dr. Joan Carles

The combination of immunotherapy and targeted therapies does not improve outcomes in previously treated advanced urothelial cancer

A study in which the VHIO has participated would seem to show that the combination of durvalumab, an anti-PD-L1 monoclonal…